Ignite Creation Date:
2025-12-26 @ 10:32 AM
Ignite Modification Date:
2026-03-02 @ 11:08 PM
Study NCT ID:
NCT00496028
Status:
COMPLETED
Last Update Posted:
2010-09-22
First Post:
2007-07-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study in Patients With Solid Tumours
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D8180C00023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Mary Stuart, MD - Medical Science Director EPT1
Old Organization:
AstraZeneca Pharmaceuticals